$SONO
Sonos Inc

2022 Q3 Form 10-Q Financial Statement

#000095017022016541 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $371.8M $399.8M $664.5M
YoY Change -1.82% 20.07% 2.93%
Cost Of Revenue $195.9M $220.7M $347.1M
YoY Change -2.43% 32.05% 0.27%
Gross Profit $175.8M $179.0M $317.4M
YoY Change -1.13% 8.0% 6.0%
Gross Profit Margin 47.3% 44.78% 47.76%
Selling, General & Admin $106.4M $104.0M $123.5M
YoY Change 0.77% 7.25% 12.55%
% of Gross Profit 60.49% 58.11% 38.9%
Research & Development $62.52M $64.95M $61.33M
YoY Change 12.49% 15.22% 17.16%
% of Gross Profit 35.55% 36.28% 19.32%
Depreciation & Amortization $8.907M $9.575M $9.217M
YoY Change -2.0% 10.06% 15.47%
% of Gross Profit 5.07% 5.35% 2.9%
Operating Expenses $168.9M $169.0M $184.8M
YoY Change 4.81% 10.18% 14.04%
Operating Profit $6.960M $10.04M $132.6M
YoY Change -58.4% -18.98% -3.49%
Interest Expense $196.0K $90.00K $98.00K
YoY Change 154.55% -50.55% -63.02%
% of Operating Profit 2.82% 0.9% 0.07%
Other Income/Expense, Net -$9.625M -$2.248M -$1.467M
YoY Change -592.33% 31.0% -136.42%
Pretax Income -$2.665M $7.794M $131.1M
YoY Change -114.26% -27.02% -7.27%
Income Tax -$2.100M -$800.0K $7.600M
% Of Pretax Income -10.26% 5.8%
Net Earnings -$597.0K $8.566M $123.5M
YoY Change -103.35% -50.26% -6.66%
Net Earnings / Revenue -0.16% 2.14% 18.58%
Basic Earnings Per Share $0.00 $0.07 $0.97
Diluted Earnings Per Share $0.00 $0.06 $0.87
COMMON SHARES
Basic Shares Outstanding 127.9M 128.1M 127.7M shares
Diluted Shares Outstanding 127.9M 139.6M 142.3M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $439.7M $606.7M $754.4M
YoY Change -34.46% -5.03% 11.3%
Cash & Equivalents $439.7M $606.7M $754.4M
Short-Term Investments
Other Short-Term Assets $23.12M $28.18M $22.53M
YoY Change -2.69% -11.95% 5.78%
Inventory $335.7M $264.4M $205.2M
Prepaid Expenses
Receivables $124.9M $111.4M $178.3M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $923.5M $1.011B $1.160B
YoY Change 1.29% 14.83% 28.8%
LONG-TERM ASSETS
Property, Plant & Equipment $75.86M $71.97M $69.00M
YoY Change 5.76% 9.87% 7.52%
Goodwill $79.82M $37.73M $37.73M
YoY Change 413.5% 142.69% 142.69%
Intangibles $96.94M $28.89M $29.86M
YoY Change 288.33% 13.58% 14.96%
Long-Term Investments
YoY Change
Other Assets $37.25M $36.40M $32.12M
YoY Change 70.68% 76.7% 90.03%
Total Long-Term Assets $319.8M $215.5M $212.4M
YoY Change 85.47% 28.18% 27.98%
TOTAL ASSETS
Total Short-Term Assets $923.5M $1.011B $1.160B
Total Long-Term Assets $319.8M $215.5M $212.4M
Total Assets $1.243B $1.226B $1.373B
YoY Change 14.68% 16.97% 28.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $308.0M $271.0M $341.3M
YoY Change 55.18% 33.12% 42.37%
Accrued Expenses $108.0M $100.3M $164.5M
YoY Change 40.24% 62.74% 70.59%
Deferred Revenue $18.33M $18.44M $17.82M
YoY Change 8.45% 0.25% 8.76%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $505.2M $463.7M $599.3M
YoY Change 26.02% 24.97% 31.49%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $880.0K $879.0K $905.0K
YoY Change -76.07% -76.21% -75.71%
Total Long-Term Liabilities $880.0K $879.0K $905.0K
YoY Change -76.07% -76.21% -75.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $505.2M $463.7M $599.3M
Total Long-Term Liabilities $880.0K $879.0K $905.0K
Total Liabilities $600.5M $554.5M $693.1M
YoY Change 20.83% 18.24% 24.52%
SHAREHOLDERS EQUITY
Retained Earnings $61.55M $62.15M $53.58M
YoY Change -200.65% -178.69% -155.7%
Common Stock $131.0K $130.0K $130.0K
YoY Change 2.34% 3.17% 7.44%
Preferred Stock
YoY Change
Treasury Stock (at cost) $65.05M $36.83M $54.88M
YoY Change 33.46% 41.53% 111.03%
Treasury Stock Shares
Shareholders Equity $642.7M $671.7M $679.6M
YoY Change
Total Liabilities & Shareholders Equity $1.243B $1.226B $1.373B
YoY Change 14.68% 16.97% 28.67%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$597.0K $8.566M $123.5M
YoY Change -103.35% -50.26% -6.66%
Depreciation, Depletion And Amortization $8.907M $9.575M $9.217M
YoY Change -2.0% 10.06% 15.47%
Cash From Operating Activities -$6.717M -$97.56M $179.9M
YoY Change -109.5% 153.4% -16.12%
INVESTING ACTIVITIES
Capital Expenditures -$9.281M -$9.310M $6.355M
YoY Change -37.68% 8.26% -43.92%
Acquisitions $27.10M
YoY Change
Other Investing Activities -$99.32M $0.00 -$27.10M
YoY Change
Cash From Investing Activities -$108.6M -$9.310M -$33.46M
YoY Change 629.22% 8.26% 195.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $31.37M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -45.42M -37.81M -$30.94M
YoY Change 83.36% -467.13% -148.06%
NET CHANGE
Cash From Operating Activities -6.717M -97.56M $179.9M
Cash From Investing Activities -108.6M -9.310M -$33.46M
Cash From Financing Activities -45.42M -37.81M -$30.94M
Net Change In Cash -160.7M -144.7M $114.3M
YoY Change -617.17% 293.16% -57.78%
FREE CASH FLOW
Cash From Operating Activities -$6.717M -$97.56M $179.9M
Capital Expenditures -$9.281M -$9.310M $6.355M
Free Cash Flow $2.564M -$88.25M $173.6M
YoY Change -97.01% 195.15% -14.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
7715000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-01
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
dei Entity Central Index Key
EntityCentralIndexKey
0001314727
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Goodwill
Goodwill
15545000
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
96936000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24450000
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1804000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10028000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
308032000
dei Document Period End Date
DocumentPeriodEndDate
2022-07-02
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38603
dei Entity Registrant Name
EntityRegistrantName
SONOS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
03-0479476
dei Entity Address Address Line1
EntityAddressAddressLine1
614 Chapala Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Barbara
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
93101
dei City Area Code
CityAreaCode
805
dei Local Phone Number
LocalPhoneNumber
965-300
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
SONO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
127252324
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
439726000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
640101000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
124884000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100779000
CY2022Q3 us-gaap Inventory Net
InventoryNet
335730000
CY2021Q4 us-gaap Inventory Net
InventoryNet
185130000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23124000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
31504000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
923464000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
957514000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75862000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71341000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28093000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33841000
CY2022Q3 us-gaap Goodwill
Goodwill
79824000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37247000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26085000
CY2022Q3 us-gaap Assets
Assets
1243230000
CY2021Q4 us-gaap Assets
Assets
1138804000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
214996000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
107993000
us-gaap Gross Profit
GrossProfit
672267000
us-gaap Gross Profit
GrossProfit
643062000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
108029000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
27250000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
77695000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18334000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
35866000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
43611000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
39544000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
505220000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
476130000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26118000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33960000
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
57487000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
53632000
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10789000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2394000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
880000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3646000
CY2022Q3 us-gaap Liabilities
Liabilities
600494000
CY2021Q4 us-gaap Liabilities
Liabilities
569762000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
131000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
129000
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
65050000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
50276000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
649449000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
690462000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
61553000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69897000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3347000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1376000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
642736000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
569042000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1243230000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1138804000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
371783000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
378672000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1436046000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357204000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
195935000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
200811000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
763779000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
714142000
CY2022Q3 us-gaap Gross Profit
GrossProfit
175848000
CY2021Q3 us-gaap Gross Profit
GrossProfit
177861000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
62522000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55578000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17826000
us-gaap Net Income Loss
NetIncomeLoss
131451000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
188798000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
164294000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
63993000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
67231000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
207684000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
198888000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42373000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38323000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
126189000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
113372000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
168888000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
161132000
us-gaap Operating Expenses
OperatingExpenses
522671000
us-gaap Operating Expenses
OperatingExpenses
476554000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
6960000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
16729000
us-gaap Operating Income Loss
OperatingIncomeLoss
149596000
us-gaap Operating Income Loss
OperatingIncomeLoss
166508000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
429000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
34000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
585000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
114000
CY2022Q3 us-gaap Interest Expense
InterestExpense
196000
CY2021Q3 us-gaap Interest Expense
InterestExpense
77000
us-gaap Interest Expense
InterestExpense
384000
us-gaap Interest Expense
InterestExpense
525000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9858000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1998000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13541000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4678000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9625000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1955000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13340000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4267000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2665000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18684000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
136256000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
170775000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2068000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
858000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4805000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3436000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-597000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17826000
us-gaap Net Income Loss
NetIncomeLoss
131451000
us-gaap Net Income Loss
NetIncomeLoss
167339000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-597000
us-gaap Net Income Loss
NetIncomeLoss
167339000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-597000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1711000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.38
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127884400
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125138279
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127886487
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120876472
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127884400
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144181632
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139502527
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139293775
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-597000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17826000
us-gaap Net Income Loss
NetIncomeLoss
131451000
us-gaap Net Income Loss
NetIncomeLoss
167339000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1711000
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-784000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1971000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
262000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2308000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17042000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
129480000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
167601000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
569042000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13232000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
31365000
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
11882000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17459000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
123481000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-360000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
679607000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16021000
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
43115000
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10720000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21225000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
8566000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
100000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
671684000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8003000
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
42611000
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10811000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18779000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
642736000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
297839000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
69505000
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5118000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14844000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
132292000
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
847000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
510209000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
49661000
CY2021Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
682000
CY2021Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
13703000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16363000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
17221000
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
199000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
579268000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12371000
CY2021Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
21047000
CY2021Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
16054000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15547000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17826000
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-784000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
587127000
us-gaap Net Income Loss
NetIncomeLoss
131451000
us-gaap Net Income Loss
NetIncomeLoss
167339000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27699000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25789000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
62000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2789000
us-gaap Share Based Compensation
ShareBasedCompensation
57463000
us-gaap Share Based Compensation
ShareBasedCompensation
46755000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
8594000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1253000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1238000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
95000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4437000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2226000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28476000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13846000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
158129000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-32333000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1587000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
17730000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
97421000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-27169000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-49769000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
21501000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-10958000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-151362000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34792000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1313000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2143000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
75657000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
246741000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24946000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34792000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
126416000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
929000
us-gaap Repayments Of Debt
RepaymentsOfDebt
25000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
117093000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21729000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
37257000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
131536000
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
33412000
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
34877000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-114177000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49930000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-10493000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1735000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-200375000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
263614000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
640101000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
407291000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
439726000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
670905000
us-gaap Interest Paid Net
InterestPaidNet
223000
us-gaap Interest Paid Net
InterestPaidNet
434000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8862000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3773000
sono Lease Liabilities Paid Net
LeaseLiabilitiesPaidNet
11185000
sono Lease Liabilities Paid Net
LeaseLiabilitiesPaidNet
15078000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
10937000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9046000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2141000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1622000
CY2022Q3 sono Numberof Countries Where Products Distributed
NumberofCountriesWhereProductsDistributed
50
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
35014000
CY2022Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
148112000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6895000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28119000
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
121486000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2357000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1547000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:5.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of estimates and judgments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="margin-left:1.667%;text-indent:3.39%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates and judgments compared to historical experience and expected trends.</span></p><p style="margin-left:1.667%;text-indent:3.39%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="margin-left:1.667%;text-indent:3.39%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In March 2020, the outbreak of the novel coronavirus (COVID-19) was declared a pandemic. While the nature of the situation is dynamic, the Company has considered the impact when developing its estimates and assumptions noted above. Actual results and outcomes may differ from management's estimates and assumptions.</span></p>
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
371783000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
378672000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1436046000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357204000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
371783000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
378672000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1436046000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357204000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
371783000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
378672000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1436046000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357204000
CY2022Q3 sono Allowance For Sales Incentives
AllowanceForSalesIncentives
20871000
CY2021Q4 sono Allowance For Sales Incentives
AllowanceForSalesIncentives
19160000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
124884000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100779000
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
258994000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
154608000
CY2022Q3 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
76736000
CY2021Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
30522000
CY2022Q3 us-gaap Inventory Net
InventoryNet
335730000
CY2021Q4 us-gaap Inventory Net
InventoryNet
185130000
CY2021Q4 us-gaap Goodwill
Goodwill
15545000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
66078000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-1799000
CY2022Q3 us-gaap Goodwill
Goodwill
79824000
CY2022Q3 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P7Y
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P5Y7M24D
CY2022Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
106773000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6895000
CY2022Q3 sono Indefinite Lived Intangible Assets Excluding Goodwill Impact
IndefiniteLivedIntangibleAssetsExcludingGoodwillImpact
-2942000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
96936000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1758000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
6180000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5968000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3367000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3038000
CY2022Q3 sono Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
7808000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28119000
CY2022Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
22700000
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
14300000
CY2022Q3 sono Accrued Advertisingand Marketing Current
AccruedAdvertisingandMarketingCurrent
14050000
CY2021Q4 sono Accrued Advertisingand Marketing Current
AccruedAdvertisingandMarketingCurrent
19989000
CY2022Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
12880000
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
16941000
CY2022Q3 sono Accrued Inventory Current
AccruedInventoryCurrent
33414000
CY2021Q4 sono Accrued Inventory Current
AccruedInventoryCurrent
37117000
CY2022Q3 sono Accrued Manufacturing Logisticsand Product Development Current
AccruedManufacturingLogisticsandProductDevelopmentCurrent
20131000
CY2021Q4 sono Accrued Manufacturing Logisticsand Product Development Current
AccruedManufacturingLogisticsandProductDevelopmentCurrent
14943000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
21117000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
13066000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6401000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5973000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
107993000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
108029000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
18800000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
89498000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
62388000
sono Contract With Customer Liability Recognition Of Period Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfPeriodDeferredRevenue
35226000
sono Contract With Customer Liability Recognition Of Period Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfPeriodDeferredRevenue
13381000
sono Contract With Customer Liability Revenue Deferred Netof Revenue Recognized On Contracts
ContractWithCustomerLiabilityRevenueDeferredNetofRevenueRecognizedOnContracts
21549000
sono Contract With Customer Liability Revenue Deferred Netof Revenue Recognized On Contracts
ContractWithCustomerLiabilityRevenueDeferredNetofRevenueRecognizedOnContracts
21379000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
75821000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
70386000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5184000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
17302000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
15251000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
12968000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
25116000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
75821000
CY2022Q3 sono Accrued Liabilities Reserve For Returns
AccruedLiabilitiesReserveForReturns
19634000
CY2021Q4 sono Accrued Liabilities Reserve For Returns
AccruedLiabilitiesReserveForReturns
19266000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10254000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10724000
CY2022Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
7428000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
5604000
CY2022Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
6295000
CY2021Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3950000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
43611000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
39544000
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5604000
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3628000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
9191000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
12218000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
7367000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
10613000
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
7428000
CY2021Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5233000
CY2022Q3 us-gaap Receivable For Recovery Of Import Duties Net
ReceivableForRecoveryOfImportDutiesNet
14300000
CY2021Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000.0
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4650276
us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
117100000
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
25.16
CY2022Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
32900000
us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
4375584
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14545239
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.86
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
282141000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3245130
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.48
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
340
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.50
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
29983
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.76
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11269786
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.26
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M12D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
52563000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10616150
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
13.20
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M6D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
50146000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
11234657
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
13.25
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y8M12D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
52424000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18779000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15547000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
57463000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
46755000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2100000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
900000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4800000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3400000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-597000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17826000
us-gaap Net Income Loss
NetIncomeLoss
131451000
us-gaap Net Income Loss
NetIncomeLoss
167339000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127884400
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125138279
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127886487
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120876472
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127884400
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144181632
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139502527
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139293775
us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
6200000
us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
5300000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.38
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8653315
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14001689
CY2022Q3 us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
2200000
CY2021Q3 us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
1800000

Files In Submission

Name View Source Status
0000950170-22-016541-index-headers.html Edgar Link pending
0000950170-22-016541-index.html Edgar Link pending
0000950170-22-016541.txt Edgar Link pending
0000950170-22-016541-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sono-20220702.htm Edgar Link pending
sono-20220702.xsd Edgar Link pending
sono-ex31_1.htm Edgar Link pending
sono-ex31_2.htm Edgar Link pending
sono-ex32_1.htm Edgar Link pending
sono-ex32_2.htm Edgar Link pending
sono-20220702_cal.xml Edgar Link unprocessable
sono-20220702_def.xml Edgar Link unprocessable
sono-20220702_lab.xml Edgar Link unprocessable
sono-20220702_pre.xml Edgar Link unprocessable
sono-20220702_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable